Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.

Megan Tjelle, a young woman from Chicago, lost an additional 50 pounds with the help of the medication Wegovy. Her story is a ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight ... start at $199 a month, while ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

People taking Zepbound, or interested in starting, will now have several vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 ...

There is currently no schedule data. The Schedule Release will be available on April.

There is currently no schedule data. The Schedule Release will be available on April.